Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance
- 1 June 1998
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 351 (9119) , 1881-1883
- https://doi.org/10.1016/s0140-6736(98)03391-1
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitorsAIDS, 1998
- Indinavir-associated lipodystrophyAIDS, 1998
- Visceral abdominal-fat accumulation associated with use of indinavirThe Lancet, 1998
- “Buffalo hump” in men with HIV-1 infectionThe Lancet, 1998
- Hypertrophy of the breasts in a patient treated with indinavir.Clinical Infectious Diseases, 1997
- Regulation of Adipose Cell Number in ManClinical Science, 1997
- Regulation of Metabolism by Retinoic Acid and its Nuclear ReceptorsAnnual Review of Nutrition, 1996
- Structure/Function of Cytoplasmic Vitamin A-Binding ProteinsAnnual Review of Nutrition, 1996
- Retinoic acid biosynthesis and metabolismThe FASEB Journal, 1996
- Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1Nature, 1989